Xylem Inc. announced robust fourth-quarter and full-year 2025 results, highlighted by a 6% increase in reported revenue to $2.4 billion for the quarter and a 20% rise in adjusted earnings per share. The full year saw record revenue of $9.0 billion and a 19% increase in adjusted EPS, driven by strong execution and broad-based demand.
Fourth-quarter orders increased by 9% on a reported basis and 7% organically, reaching $2.4 billion.
Fourth-quarter revenue grew by 6% on a reported basis and 4% organically, totaling $2.4 billion.
Adjusted earnings per share for Q4 2025 were $1.42, a 20% increase from the previous year.
Full-year 2025 revenue reached a record $9.0 billion, up 6% reported and 5% organically, with adjusted EPS of $5.08, up 19%.
Xylem forecasts continued resilient underlying demand for 2026, with expected revenue growth and improved adjusted EBITDA and free cash flow margins.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance